SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF is seeing heightened interest as investors treat memory chips as a structural bottleneck for AI infrastructure rather than a traditional cyclical trade. Community sentiment remains aggressively bullish, with participants pointing to surging demand for HBM and upcoming earnings as catalysts for a potential multi-year re-rating of the sector.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending following a massive surge in volume and price action driven by strong quarterly results, including record revenue growth and positive operating cash flow. The community is focused on the successful validation of the company's 'Butterfly Embedded' strategy, with intense debate centering on whether the stock can sustain its momentum or if it will face a typical post-hype correction.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture is facing significant market pressure following a revenue outlook that missed expectations and a major acquisition strategy that sparked investor concerns over integration risks. While some community members remain focused on the company's long-term value and cybersecurity expansion, many are debating whether AI disruption and a shifting consulting model are permanently damaging the firm's growth prospects.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors eagerly await a series of high-impact catalysts, including long-term trial results, while the community intensely debates potential M&A scenarios and the company's competitive positioning in the dermatology and immunology space.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing strong community momentum following a joint research agreement with Honda to advance solid-state battery technology and manufacturing processes. Investors and traders are actively discussing the significance of this OEM validation, with many pointing to the partnership as a critical de-risking event that could accelerate commercialization and shift sentiment around the stock.

XYO is the original and one of the largest Decentralized Physical Infrastructure Networks (DePIN), boasting over 10 million nodes and consistently leading DePIN in both scale and revenue generation. Launching its Mainnet ahead of any other DePIN, XYO specializes in collecting and validating real-world data, bridging it seamlessly to Web3 and Web2 companies across AI, geolocation, and other critical data sectors. At the core of XYO are Proof of Location and Proof of Origin technologies, enabling accurate validation of real-world data for innovative use cases such as Real-World Asset (RWA) tracking, DePIN applications, real-world gaming, and treasure hunts. Recently, XYO expanded its ecosystem by launching the XYO Layer One blockchain, purpose-built to support the intensive data demands of DePIN, RWA, AI, and similar data-driven industries. XYO employs a unique dual-token model: XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases. The dual-token economics are strategically designed to increase scarcity and promote sustainable growth. The XYO token is available on major exchanges, including Coinbase. The XL1 token will launch publicly later in 2025. To accelerate network adoption and growth, XYO created the popular COIN app. Beyond the XYO Foundation, the team founded the U.S.-based, for-profit entity XY Labs Inc., notable as the first U.S. crypto company qualified by the SEC for a Regulation A offering, permitting share sales to both accredited and non-accredited investors. XY Labs further stands out as one of the pioneering U.S. companies to tokenize and publicly list its shares. These tokenized shares trade as $XYLB on the tZERO ATS, positioning XY Labs prominently in the growing wave of Real-World Asset (RWA) tokenization.

XYO Network

XYO Network is currently generating significant social media activity as traders debate the project's long-term utility in the DePIN sector versus its history of volatile pump-and-dump price action. While some community members remain optimistic about future partnerships and institutional adoption, many participants are expressing frustration over stagnant price performance and the introduction of secondary tokens.

Horizon Quantum Holdings Ltd. engages in the development of software tools. The company is headquartered in Singapore.

Horizon Quantum Holdings Ltd. - Ordinary Shares - Class A

Horizon Quantum Holdings is attracting significant community attention due to its low float and strategic partnerships with major industry players, fueling intense volume and speculation of a potential short squeeze. Traders are actively debating whether the companys quantum software focus represents a breakthrough infrastructure play or a speculative meme stock prone to volatility.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is facing significant regulatory headwinds as the FCC initiates an accelerated review of the company's broadcast licenses amid ongoing investigations into its corporate diversity policies. Meanwhile, community sentiment remains polarized, with investors weighing the potential impacts of executive leadership transitions and persistent political scrutiny on the stock's long-term performance.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors react to the company's strong clinical pipeline and the validation of its CAN-2409 therapy, with significant community discussion focused on potential institutional accumulation and the stock's positioning ahead of major regulatory milestones. While some participants speculate about imminent trial catalysts and long-term buyout potential, others are actively debating the impact of institutional ownership versus the high levels of short interest in the biotech sector.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital Inc. is trending as investors bet on the company’s potential as a data center and power infrastructure play, with significant community excitement surrounding its upcoming Russell 3000 index inclusion and anticipated hyperscaler lease deals. The conversation is heavily driven by optimistic outlooks on the company’s land holdings and recent strategic hires, though discussions remain divided between long-term bullish sentiment and frustrations over historical price manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade

Johnson & Johnson (JNJ) reached $228.39 at the closing of the latest trading day, reflecting a -2.48% change compared to its last close.

Top Research Reports for Alphabet, Broadcom & Johnson & Johnson

Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Broadcom Inc. (AVGO) and Johnson & Johnson (JNJ), as well as two micro-cap stocks, Franklin Wireless Corp. (FKWL) and Park Aerospace Corp. (PKE).

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Can BMY's Camzyos Strengthen Its Cardiovascular Portfolio?

Bristol Myers eyes growth from Camzyos as the FDA reviews its use in adolescents with obstructive HCM, expanding the drug's market reach.

Johnson & Johnson CEO credits Trump tax policy for $55B US investment push, including $1B in Florida

Johnson & Johnson is betting big on America, crediting Trump tax policies, top talent and a strong investment environment for inspiring a $55 billion U.S. investment push that spotlights growing confidence in U.S. manufacturing."We have the best talent, we have the best investment environment and...

AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?

AZN shares fell after a camizestrant setback, but blockbuster drugs, oncology growth and a deep pipeline support long-term targets.

AstraZeneca's Truqap Wins FDA Nod for Prostate Cancer Indication

AZN wins FDA approval to expand Truqap's use in PTEN-deficient prostate cancer, backed by phase III data showing improved outcomes and broader use.

Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida

Johnson & Johnson (NYSE: JNJ) (the Company), healthcares leading, most comprehensive innovation powerhouse, today announced an investment of more than $1 billion in Jacksonville, Florida to strengthen its Vision operations by scaling U.S.-based manufacturing, packaging and distribution...

Jim Cramer Explains Johnson & Johnson's (JNJ) Shares Have Gained

Jim Cramer Explains Johnson & Johnson's (JNJ) Shares Have Gained...

New TALVEY (talquetamab-tgvs) plus DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

New TALVEY (talquetamab-tgvs) plus DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma New TALVEY (talquetamab-tgvs) plus DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) data...

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

JNJ Reports Promising Survival Data From CHRYSALIS-2 Lung Cancer Study

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$228.39
Prev Close	$234.20
Open	$231.78
Dividend Yield	2.48%
50-Day Moving Average	$230.37
Beta	0.03
Avg. Volume	7.72M
PE Ratio	26.41

52-Week High	$251.71
52-Week Low	$149.04
Market Capitalization	$563.77B
EPS (Annual)	$11.03
Price to Book	6.77
Revenue Per Employee	$668,877.84

JNJJohnson & Johnson

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest JNJ News